Aerocrine AB Receives FDA Clearance for NIOX VERO® BlueTooth® Wireless Enhancement

Business News
Print
SOLNA, Sweden--(BUSINESS WIRE)--Aerocrine AB (STO:AEROB) announces today that clearance was received for its FeNO measuring device to operate wirelessly with BlueTooth® technology in the US. The US FDA has granted Aerocrine AB regulatory clearance for NIOX VERO® through a special 510k to utilize BlueTooth® wireless technology to send FeNO measurements and patient data between the NIOX VERO and the healthcare providers’ computers. This cordless enhancement allows the device to go with a healthca

imageimage

Read more